Document is current
Any future updates will be listed below
-
Authors
Hamouda, Ahmed E. I. https://orcid.org/0000-0001-6532-9585
Filtjens, Jessica
Brabants, Elisabeth
Kancheva, Daliya https://orcid.org/0000-0001-6222-0461
Debraekeleer, Ayla
Brughmans, Jan
Jacobs, Lotte
Bardet, Pauline M. R. https://orcid.org/0000-0003-4454-9823
Knetemann, Elisabeth https://orcid.org/0000-0003-4975-1844
Lefesvre, Pierre
Allonsius, Lize https://orcid.org/0000-0002-4133-5021
Gontsarik, Mark https://orcid.org/0000-0001-7613-5137
Varela, Ismael https://orcid.org/0000-0002-3825-372X
Crabbé, Marian
Clappaert, Emile J.
Cappellesso, Federica
Caro, Aarushi A.
Gordún Peiró, Alícia https://orcid.org/0000-0001-7286-9846
Fredericq, Luna
Hadadi, Eva
Estapé Senti, Mariona
Schiffelers, Raymond https://orcid.org/0009-0004-2423-209X
van Grunsven, Leo A. https://orcid.org/0000-0002-0990-7034
Aboubakar Nana, Frank
De Geest, Bruno G. https://orcid.org/0000-0001-9826-6170
Deschoemaeker, Sofie https://orcid.org/0000-0001-5449-282X
De Koker, Stefaan
Lambolez, Florence
Laoui, Damya https://orcid.org/0000-0002-3373-1403
-
Funding
Funding for this research was provided by:
Vrije Universiteit Brussel (starters grant)
Vlaams Instituut voor Biotechnologie
Stichting Tegen Kanker
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 25 November 2024
First Online: 6 December 2024
Competing interests
: J.F., E.B., S.D.K., and F.L. are employees of etherna. J.F., E.B., S.D.K., and F.L. have applied for a patent related to the study (Compositions and methods for delivery of agents to immune cells; WO2023118411A1). S.D.K. and B.G.D.G. have applied for a patent related to the ionizable lipids used in this work (Ionizable lipids; WO2022136641A1). All other authors declare no potential conflicts of interest.
